Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vita 34 AG (V3V) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3476
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vita 34 AG (Vita 34), formerly Vita 34 International AG, is an umbilical cord blood bank that collects, prepares, processes, deposits, and stores stem cells from umbilical cord blood. The company’s products comprise vitaplus, vitaplus25, vitaplus50, vitapluscordtissue, vitapluscordtissue25, and vitapluscordtissue50. Vita 34 conducts research on umbilical cord blood used in acquired hearing loss, early childhood brain damage, aplastic anemia, blood cancer, solid tumors, type 1 diabetes, and gene therapy for severe immune deficiency. The company also provides vitaplus donation, and preventive screening services. It has operations in the US, Austria, Switzerland and Spain. Vita 34 is headquartered in Leipzig, Germany.

Vita 34 AG (V3V) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9
Vita 34 AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vita 34 AG, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Vita 34 to Acquire Assets from Vivocell Biosolutions for USD0.8 Million 11
Equity Offering 12
Vita 34 Raises USD5.4 Million in Rights Offering of Shares 12
Acquisition 13
VITA 34 Acquires 100% Stake in Seracell Pharma 13
Vita 34 Acquires 30% Stake in Bio Save 14
VITA 34 Acquires 75.24% Stake In Stellacure 15
Medivision Acquires 51% Stake In Stellacure From Cord Blood America 16
VITA 34 Acquires BioPlanta, Developer Of Active Herbal Ingredients 17
Vita 34 AG – Key Competitors 18
Vita 34 AG – Key Employees 19
Vita 34 AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 08, 2017: Vita 34 adjusts revenues and earnings targets for 2017 21
Feb 01, 2017: Vita 34 increased its turnover in 2016 by 14 per cent in comparison to the previous year 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Vita 34 AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9
Vita 34 AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Vita 34 to Acquire Assets from Vivocell Biosolutions for USD0.8 Million 11
Vita 34 Raises USD5.4 Million in Rights Offering of Shares 12
VITA 34 Acquires 100% Stake in Seracell Pharma 13
Vita 34 Acquires 30% Stake in Bio Save 14
VITA 34 Acquires 75.24% Stake In Stellacure 15
Medivision Acquires 51% Stake In Stellacure From Cord Blood America 16
VITA 34 Acquires BioPlanta, Developer Of Active Herbal Ingredients 17
Vita 34 AG, Key Competitors 18
Vita 34 AG, Key Employees 19
Vita 34 AG, Subsidiaries 20

List of Figures
Vita 34 AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vita 34 AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vita 34 AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vita 34 AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Vita 34 AG (V3V):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pt Mandom Indonesia Tbk:企業の戦略・SWOT・財務情報
    Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Mandom Indonesia Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Enel SpA:企業の戦略・SWOT・財務情報
    Enel SpA - Strategy, SWOT and Corporate Finance Report Summary Enel SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cellnet Group Ltd (CLT):企業の財務・戦略的SWOT分析
    Cellnet Group Ltd (CLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Photo-Me International plc (PHTM):企業の財務・戦略的SWOT分析
    Summary Photo-Me International Plc (Photo-Me) is a consumer goods provider that offers photographic products. The company offers optical and instant service equipment. It operates a range of vending equipment such as self-service launderettes, digital printing kiosks, children rides and amusement ma …
  • Service Corporation International:企業の戦略・SWOT・財務分析
    Service Corporation International - Strategy, SWOT and Corporate Finance Report Summary Service Corporation International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Louisville Gas and Electric Co:電力:M&Aディール及び事業提携情報
    Summary Louisville Gas and Electric Company (LG&E) a subsidiary of LG&E and KU Energy LLC is an electric and natural gas utility. The utility offers gas storage and distribution services to residential and business customers. It has a total regulated generation capacity of three thousand megawatts. …
  • Colbun SA:発電所・企業SWOT分析
    Colbun SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Austrian Post:企業の戦略・SWOT・財務情報
    Austrian Post - Strategy, SWOT and Corporate Finance Report Summary Austrian Post - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • BioMedomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops and markets immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube base …
  • BRF SA:企業の戦略・SWOT・財務分析
    BRF SA - Strategy, SWOT and Corporate Finance Report Summary BRF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Wintrust Financial Corporation:企業のM&A・事業提携・投資動向
    Wintrust Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wintrust Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Re-Vana Therapeutics Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Re-Vana Therapeutics Ltd (Re-Vana) is an ocular pharmaceutical and drug delivery company that develops and commercialization of biodegradable long- acting drug delivery platforms to treat ophthalmic conditions. The company provides drug delivery products such as OcuLief, an injectable platfo …
  • Inovise Medical, Inc.:企業の戦略的SWOT分析
    Inovise Medical, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bangchak Corporation PCL (BCP):企業の財務・戦略的SWOT分析
    Bangchak Corporation PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • aTyr Pharma Inc (LIFE):企業の財務・戦略的SWOT分析
    Summary ATyr Pharma Inc (ATyr Pharma) is a clinical-stage biotechnology company engaged in the discovery and clinical development of medicines for the treatment of cancer and lung diseases. Its ATYR1923 is a clinical-stage product candidate, based on the resokine pathway, which binds to the neuropil …
  • United Biscuits (UK) Limited:企業の戦略・SWOT・財務情報
    United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • RGC Resources Inc (RGCO):企業の財務・戦略的SWOT分析
    Summary RGC Resources Inc (RGC Resources) is an energy company that distributes natural gas. The company offers home appliances such as gas furnaces, natural gas water heaters, gas dryers and ranges, gas logs and space heaters, gas generators, gas grills and gas lights, among others. It offers natur …
  • Verathon Inc:企業の戦略的SWOT分析
    Verathon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • F. Hoffmann-La Roche Ltd:企業のM&A・事業提携・投資動向
    F. Hoffmann-La Roche Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's F. Hoffmann-La Roche Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • PT Apexindo Pratama Duta Tbk (APEX):企業の財務・戦略的SWOT分析
    PT Apexindo Pratama Duta Tbk (APEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆